RESOLUTION MEDICAL APPOINTS DAVID BLAESER AS NEW CEO
May 18, 2020
Resolution Medical Using Carbon DLS™ Technology to 3D Print Nasopharyngeal Swabs for COVID-19 Testing, Scaling up to Over 1 Million Per Week
April 8, 2020
To help increase COVID-19 testing capacity, today, Resolution Medical, an FDA registered, in vitro diagnostic and medical device manufacturer, announced the launch of The Resolution Medical Lattice Swab, Crafted with Carbon™ Technology. Resolution Medical has already sent the new 3D printed nasopharyngeal swabs for COVID-19 testing to healthcare organizations and is able to provide swabs to others in the United States who order on its website. Manufactured using Carbon Digital Light Synthesis™ (DLS™) technology and KeySplint Soft® Clear material for Carbon printers from Keystone® Industries, the Lattice Swab is classified by the FDA as a Class I 510(k) Exempt in vitro diagnostic medical device. Read full Press release here.
RESOLUTION MEDICAL CLOSES OUT 2019 WITH 100TH HIRE
DECEMBER 28, 2019
Resolution Medical has surpassed a major milestone in hiring its 100th employee. Starting in 2012 with only two founders, no investors, and limited capital, the company has now created over 100 new positions in Minneapolis, Minnesota. 2020 looks to be another year of continued growth as the company continues to add additional positions in both manufacturing and development.